
Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,781 products)
- Apoptosis(6,260 products)
- Cell Cycle/Checkpoint(4,792 products)
- Chromatin/Epigenetics(2,440 products)
- Cytoskeletal Signaling(1,527 products)
- DNA Damage/DNA Repair(2,968 products)
- Endocrinology/Hormones(3,706 products)
- Enzyme(3,667 products)
- GPCR/G-Protein(9,005 products)
- Immunology and Inflammation(3,874 products)
- Influenza Virus(301 products)
- JAK/STAT signaling(414 products)
- MAPK Signaling(1,248 products)
- Membrane Transporter/Ion Channel(3,033 products)
- Metabolism(10,207 products)
- Microbiology/Virology(7,591 products)
- Neuroscience(10,382 products)
- Other Inhibitors(36,042 products)
- Oxidation-Reduction(42 products)
- PI3K/Akt/mTOR Signaling(1,444 products)
- Proteases/Proteasome(1,724 products)
- Stem Cell and Derivatives(825 products)
- Tyrosine Kinase/Adaptors(2,035 products)
- Ubiquitination(1,717 products)
Show 16 more subcategories
Found 66686 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Rad 243
CAS:Rad 243 is a sodium channel blocker with antiarrhythmic activity.Formula:C18H30N2OPurity:98%Color and Shape:SolidMolecular weight:290.44OUL245
CAS:OUL245: A selective PARP2 inhibitor (IC50=44nM), also inhibits other PARPs/TNKS (IC50=2.9-8.8μM).Formula:C8H5N3OSColor and Shape:SolidMolecular weight:191.21FLT3-IN-11
CAS:FLT3-IN-11, an oral FLT3 kinase inhibitor: potent, selective, IC50 - wild-type 7.22 nM, FLT3-D835Y 4.95 nM, anti-AML IC50 3.2 nM for MV4-11.Formula:C20H25F3N6OColor and Shape:SolidMolecular weight:422.45Tomoxiprole
CAS:Tomoxiprole is a cyclooxygenase-2-selective inhibitor.Formula:C21H20N2OColor and Shape:SolidMolecular weight:316.4M-25
CAS:M-25 is a Smoothened antagonist and inhibitor of the Hedgehog pathway.Formula:C23H29N3O2Color and Shape:SolidMolecular weight:379.5MS-0022
CAS:MS-0022: SMO antagonist, inhibits Hh signaling in nM-µM ranges, curbs tumor cell growth, and delays tumor progression in vivo.Formula:C21H16BrN3OColor and Shape:SolidMolecular weight:406.28NY0123
CAS:NY0123 is an active EPAC antagonist with low micromolar inhibitory activity.Formula:C16H13Cl3N4O2Color and Shape:SolidMolecular weight:399.66Antiproliferative agent-19
Antiproliferative agent-19 induces apoptosis and G2/M cell cycle arrest in lung cancer cells.Formula:C26H23NOColor and Shape:SolidMolecular weight:365.47RSK2-IN-3
CAS:RSK2-IN-3 (Compound 26) is a covalent, reversible inhibitor of RPS6KA3 (RSK2) kinase.Formula:C24H26N4O5Color and Shape:SolidMolecular weight:450.49Y2-Antagonist-2
CAS:Y2-Antagonist-2 is a novel, selective, soluble non-peptidic NPY Y2 receptor antagonist with enhanced CNS exposure.Formula:C27H33ClF3N5OColor and Shape:SolidMolecular weight:536.03Dicentrine HCl
CAS:Dicentrine HCl is the salt form of Dicentrine, an alpha 1-adrenoceptor antagonist effective against human hyperplastic prostates.Formula:C20H22ClNO4Color and Shape:SolidMolecular weight:375.85Chinotilin
CAS:Chinotilin is a muscle relaxant antagonist.Formula:C26H26IN2O4Color and Shape:SolidMolecular weight:557.408Antitubercular agent-27
CAS:Antitubercular agent-27: IC50=3.2 μM, MIC=7.8 μM, IC90=7.0 μM; effective against resistant Mycobacterium tuberculosis, low toxicity.Formula:C14H8BrN3O3Color and Shape:SolidMolecular weight:346.14OK-1035
CAS:OK-1035: Potent, selective DNA-PK inhibitor; 50% inhibition at 8 μM; ATP-competitive; affects p53 phosphorylation.Formula:C12H9N5OColor and Shape:SolidMolecular weight:239.23Z-335 sodium
CAS:Z-335 Salt, a thromboxane A2 receptor antagonist, is used potentially for the treatment of arterial occlusive disease.Formula:C18H18ClNNaO4SColor and Shape:SolidMolecular weight:402.84Axl-IN-8
CAS:Axl-IN-8 (NO.1) is a potent inhibitor of AXL (IC50<1 nM) and also inhibits c-MET (IC50: 1-10 nM). : 120.3 nM).Formula:C31H29FN6O3Color and Shape:SolidMolecular weight:552.6P2X7 receptor antagonist-2
CAS:P2X7 receptor antagonist-2: potent, pIC50 6.5-7.5, reduces neuroinflammation.Formula:C19H18Cl2N2O2Color and Shape:SolidMolecular weight:377.26Carbonic anhydrase inhibitor 11
CAS:Potent carbonic anhydrase inhibitor VI targets CA II, IX, XII with Ki: 40, 39, 900 nM respectively.Formula:C19H15F3N4O3S2Color and Shape:SolidMolecular weight:468.47Ricinelaidic Acid
CAS:Ricinelaidic acid blocks LTB4 receptors; hampers human neutrophil responses; reduces rat bronchoconstriction by 46% at 1 mg/kg i.v.Formula:C18H34O3Color and Shape:SolidMolecular weight:298.46SFOM-0046
CAS:SFOM-0046, an anticancer drug, halts S-phase cell cycle, induces DNA stress, and phosphorylates H2AX to γ-H2AX.Formula:C17H20N2O4SColor and Shape:SolidMolecular weight:348.42L-826266
CAS:L-826266 is an antagonist of EP(1) receptor.Formula:C27H21BrClNO4SColor and Shape:SolidMolecular weight:570.88SN05
CAS:SN05 inhibits AAT with Ki: ASCT1 (2.77μM), rASCT2 (0.73μM), hASCT2 (0.87μM), EAAT1-5 (3.7-7.25μM); used in cancer research.Formula:C18H17NO4Color and Shape:SolidMolecular weight:311.33Noberastine maleate
CAS:Noberastine maleate, a fast-acting furan-derived H1 antagonist, peaks at 4 hours with minimal CNS effects and maximal efficacy at 30 mg/day.Formula:C25H29N5O9Color and Shape:SolidMolecular weight:543.53Quinidine Monosulfate
CAS:Quinidine Monosulfate: an oral antiarrhythmic, CYP450db inhibitor, K+ blocker (IC50 19.9 μM), used in malaria research.Formula:C40H50N4O8SColor and Shape:SolidMolecular weight:746.92PF-06455943
CAS:PF-06455943: LRRK2 inhibitor, IC50=3nM, PET radioligand, used for ADME/neuro PK & Parkinson's research.Formula:C17H14FN5OColor and Shape:SolidMolecular weight:323.32MDL-801
CAS:MDL-801 is an activator of SIRT6 deacetylation.Formula:C20H14BrCl2FN2O6S2Color and Shape:SolidMolecular weight:612.27Laidlomycin butyrate
CAS:Laidlomycin butyrate is a ionophore with enhanced intraruminal activity.Formula:C41H68O13Color and Shape:SolidMolecular weight:768.97SMM-189
CAS:SMM-189 is a potent and selective CB2 inverse agonist.Formula:C19H12Cl2O3Color and Shape:SolidMolecular weight:359.2simufilamum
CAS:Simufilam (PTI-125): Low-toxicity, oral drug activating FLNA, correcting its structure, aiding Alzheimer's research.Formula:C15H21N3OColor and Shape:SolidMolecular weight:259.35Sermetacin
CAS:Sermetacin is an anti-inflammatory agent.Formula:C22H21ClN2O6Purity:98%Color and Shape:SolidMolecular weight:444.86SARS-CoV-2 nsp3-IN-2
CAS:SARS-CoV-2 nsp3-IN-2: Mac1 inhibitor, IC50=180μM, hinders virus replication.Formula:C10H12N4O2Color and Shape:SolidMolecular weight:220.23DHPM-93
CAS:DHPM-93 is a the most potent inhibitor of sodium iodide symporter (nis) reported to dateFormula:C18H18N2O5Color and Shape:SolidMolecular weight:342.35BMS-37
CAS:BMS-37 is a novel inhibitor of PD-1/PD-L1 immune checkpoint.Formula:C27H32N2O4Color and Shape:SolidMolecular weight:448.55CJ-17493 (free base)
CAS:CJ-17493 (free base) is a Neurokinin-1 Receptor Antagonist.Formula:C24H29F3N2O2Color and Shape:SolidMolecular weight:434.49Etamiphylline Camsylate
CAS:Etamiphylline Camsylate is used for the treatment of chronic obstructive pulmonary disease (COPD).Formula:C23H37N5O6SColor and Shape:SolidMolecular weight:511.64(S)-GFB-12811
CAS:(S)-GFB-12811, a CDK5 inhibitor with IC50<10 nM, aids research in cell cycle, neuronal growth, and cancer.Formula:C22H23F4N5OColor and Shape:SolidMolecular weight:449.44αβ-Tubulin-IN-1
CAS:αβ-Tubulin-IN-1 is a potent and orally active inhibitor of αβ-Tubulin.Formula:C25H19N3O3Color and Shape:SolidMolecular weight:409.44Montelukast cyclopropaneacetamide
CAS:Montelukast, an LTRA, treats asthma and eases seasonal allergy symptoms.Formula:C35H37ClN2O2SColor and Shape:SolidMolecular weight:585.2DPP-4-IN-1
CAS:DPP-4-IN-1 inhibits DPP-4 with 49 nM IC50, ideal for diabetes study, akin to Alogliptin.Formula:C19H19ClN6Color and Shape:SolidMolecular weight:366.85CCR8 antagonist 2
CAS:CCR8 antagonist 2 blocks CCR8 activity, mainly on Treg and Th2 cells, for treating related diseases. See WO2022000443A1, compound 220.Formula:C23H30ClN3O3SColor and Shape:SolidMolecular weight:464.02N-2733 HCl
CAS:N-2733 HCl is a nuclear factor (NF)-kappaB activation inhibitor.Formula:C12H13ClN2O2Color and Shape:SolidMolecular weight:252.7BBS-4
CAS:BBS-4 inhibits NOS2 dimerization (IC50: 0.49 nM), guarding mice against sepsis-related heart issues.Formula:C22H24N6O3Color and Shape:SolidMolecular weight:420.46TRK-IN-15
CAS:TRK-IN-15 (X-55): potent TRK kinase inhibitor, aids in TRK-related disease research.Formula:C19H20FN5OColor and Shape:SolidMolecular weight:353.39(R)-N-Desmethyl PK11195
CAS:(R)-N-Desmethyl PK11195 is a precursor for (R)-[N-Methyl-11C-]PK11195.Formula:C20H19ClN2OColor and Shape:SolidMolecular weight:338.83AH 19437
CAS:AH 19437 is a prostanoid receptor.Formula:C24H33NO5Color and Shape:SolidMolecular weight:415.52SB26019
CAS:SB26019: Potent anti-neuroinflammation; inhibits NF-κB via α-tubulin monomers preventing p65 translocation.Formula:C24H20O4Color and Shape:SolidMolecular weight:372.41Benzoic acid, m-(2-methyl-5-phenylpyrrol-1-yl)-, compd. with morpholine (1:1)
CAS:Benzoic acid, m-(2-methyl-5-phenylpyrrol-1-yl)-, compd. with morpholine (1:1) is a bioactive chemical.Formula:C22H24N2O3Color and Shape:SolidMolecular weight:364.44WEB2347
CAS:WEB2347 is a novel, potent and long acting antagonist of hetrazepinoic PAF.Formula:C25H28ClN5OSColor and Shape:SolidMolecular weight:482.04SC 51089 free base
CAS:SC 51089 free base is a selective antagonist of the prostaglandin E2 EP1 receptor, demonstrating neuroprotective activity.Formula:C22H19ClN4O3Color and Shape:SolidMolecular weight:422.86Ridazolol
CAS:Ridazolol is a vasodilating and cardioselective beta adrenergic blocker.Formula:C15H18Cl2N4O3Purity:99.05%Color and Shape:SolidMolecular weight:373.23
